Very late relapse with rapid BCR‐ABL1 BCR‐ABL1 elevation after more than seven?years of treatment‐free remission with undetectable molecular residual disease in chronic myeloid leukaemia

Katagiri Seiichiro; Gotoh Akihiko; Ohyashiki Kazuma

首页> 外文期刊>British Journal of Haematology >Very late relapse with rapid BCR‐ABL1 BCR‐ABL1 elevation after more than seven?years of treatment‐free remission with undetectable molecular residual disease in chronic myeloid leukaemia

【24h】

Very late relapse with rapid BCR‐ABL1 BCR‐ABL1 elevation after more than seven?years of treatment‐free remission with undetectable molecular residual disease in chronic myeloid leukaemia

机译：快速复发与快速BCR-ABL1 BCR-ABL1升高超过七年以上的治疗慢性骨髓白血病免测分子残留疾病

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《British Journal of Haematology》 |2020年第2期|共3页
作者
Katagiri Seiichiro; Gotoh Akihiko; Ohyashiki Kazuma;
展开▼
作者单位

Department of HematologyTokyo Medical UniversityTokyo Japan;

Department of HematologyTokyo Medical UniversityTokyo Japan;

Department of HematologyTokyo Medical UniversityTokyo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词
chronic myeloid leukaemia; imatinib; treatment‐free remission; late relapse; BCR‐ABL1;

机译：慢性骨髓白血病;伊马替尼;无治疗缓解;迟到复发;BCR-ABL1;

相似文献

外文文献
中文文献
专利

1. Very late relapse with rapid BCR‐ABL1 BCR‐ABL1 elevation after more than seven?years of treatment‐free remission with undetectable molecular residual disease in chronic myeloid leukaemia [J] . Katagiri Seiichiro, Gotoh Akihiko, Ohyashiki Kazuma British Journal of Haematology . 2020,第2期

机译：快速复发与快速BCR-ABL1 BCR-ABL1升高超过七年以上的治疗慢性骨髓白血病免测分子残留疾病
2. Interphase FISH for BCR‐ABL1 BCR‐ABL1 rearrangement on neutrophils: A decisive tool to discriminate a lymphoid blast crisis of chronic myeloid leukemia from a de novo BCR‐ABL1 BCR‐ABL1 positive acute lymphoblastic leukemia [J] . Balducci Estelle, Loosveld Marie, Rahal Ilhem, Hematological oncology . 2018,第1期

机译：BCR-ABL1 BCR-ABL1对中性粒细胞重新排列的差异：一种决定性的工具，用于从DE Novo BCR-ABL1 BCR-ABL1阳性急性淋巴细胞间白血病中区分慢性骨髓白血病的淋巴爆炸危机
3. Chronic myeloid leukaemia, BCR‐ABL1 BCR‐ABL1 ‐positive, in accelerated phase with marked eosinophilia with eosinophil atypia [J] . Richardson Aida I., Skikne Barry S., Woodroof Janet British Journal of Haematology . 2020,第5期

机译：慢性髓性白血病，BCR-ABL1 BCR-ABL1 - 阳性，加速相，具有标记为嗜酸性粒细胞的嗜酸性粒细胞
4. ELEVATION OF MINIMAL RESIDUAL DISEASE (MRD) IN THE PERIPHERAL BLOOD PRIOR TO THE CLINICAL RELAPSE IN DOGS WITH LYMPHOMA THAT ACHIEVED COMPLETE REMISSION AFTER CHEMOTHERAPY [C] . Masahiko Sato, Junpei Yamazaki, Yuko Goto-Koshino, Annual Conference of the Veterinary Cancer Society . 2009

机译：在淋巴瘤患者临床复发之前在外周血中的最小残留疾病（MRD）升高，从而在化疗后取得完全缓解
5. Suppression of BCR-ABL by siRNA-loaded nanoparticles for the treatment of Chronic Myeloid Leukemia [D] . Gavrilov, Kseniya Eugene. 2015

机译：载有siRNA的纳米颗粒抑制BCR-ABL用于治疗慢性粒细胞白血病
6. Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines [O] . Anna Virgili, Elisabeth P Nacheva 2010

机译：慢性粒细胞白血病中BCR / ABL1和ABL1下游区域的基因组扩增：CML患者和细胞系的FISH定位研究
7. Very late relapse with rapid BCR‐ABL1 elevation after more than seven years of treatment‐free remission with undetectable molecular residual disease in chronic myeloid leukaemia [O] . Seiichiro Katagiri, Akihiko Gotoh, Kazuma Ohyashiki 2019

机译：在慢性骨髓白血病未检测到的未检测到的分子残留疾病后，在慢性骨髓性白血病未检测到的分子残留疾病后七年以上的快速BCR-ABL1高度复发

Very late relapse with rapid BCR‐ABL1 BCR‐ABL1 elevation after more than seven?years of treatment‐free remission with undetectable molecular residual disease in chronic myeloid leukaemia

著录项

相似文献

相关主题

期刊订阅